FIXX - Q32 Bio Inc.
Close
0.96
0.960 100.000%
Share volume: 0
Last Updated: Mon 25 Mar 2024 05:01:38 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Fundamental analysis
22%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
35%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
4.29%
6 Months
24.37%
1 Year
8,192.77%
2 Year
3,879.83%
Key data
Stock price
$0.96
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.60 - $53.79
52 WEEK CHANGE
$8,130.80
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
03/07/2024
Company detail
CEO: Arthur Tzianabos
Region: US
Website: https://www.homologymedicines.com/
Employees: 131
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: https://www.homologymedicines.com/
Employees: 131
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Recent news